NCT01700608 Prospective Observational Study on Plerixafor After Chemotherapy Status COMPLETED Phase N/A
NCT01624701 Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells Status TERMINATED Phase PHASE1/PHASE2
NCT01543100 Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy Status COMPLETED Phase NA
NCT01532635 A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Status TERMINATED Phase PHASE2
NCT01531998 Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) Status COMPLETED Phase PHASE1/PHASE2
NCT01526096 Stem Cell Transplantation for Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01521611 Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy Status COMPLETED Phase PHASE1/PHASE2
NCT01518153 Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) Status TERMINATED Phase PHASE2
NCT01440582 Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients Status COMPLETED Phase PHASE1
NCT01432600 Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide Status COMPLETED Phase PHASE1/PHASE2
NCT01413178 A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01396200 Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine Status COMPLETED Phase EARLY_PHASE1
NCT01350258 Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps Status TERMINATED Phase PHASE1/PHASE2
NCT01332617 Phase II Study of Simvastatin for Relapsed/Refractory Myeloma Status WITHDRAWN Phase PHASE2
NCT01302366 A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma Status TERMINATED Phase PHASE2
NCT01283997 Prevention of Treatment Induced Neuropathy in Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01279694 Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP) Status COMPLETED Phase PHASE1/PHASE2
NCT01269593 PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT01248455 A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma Status TERMINATED Phase PHASE2